DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR OXYCODONE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Oxycodone Hydrochloride

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000273	A Laboratory Model for Heroin Abuse Medications - 8	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	1995-08-01	The purpose of this study is to evaluate the effects of treatment medications (methadone, buprenorphine, LAAM, naltrexone, naltrexone microcapsules, and methoclocinnamox) on I.V. and smoked heroin self-administration."
NCT00000273	A Laboratory Model for Heroin Abuse Medications - 8	Completed	New York State Psychiatric Institute	Phase 2	1995-08-01	The purpose of this study is to evaluate the effects of treatment medications (methadone, buprenorphine, LAAM, naltrexone, naltrexone microcapsules, and methoclocinnamox) on I.V. and smoked heroin self-administration."
NCT00027014	Herb-Opioid Interactions	Completed	National Center for Complementary and Integrative Health (NCCIH)	Phase 4	2001-09-01	This is a series of studies in healthy volunteers to assess the potential for adverse interactions between St. John's wort (SJW) extract and two narcotic (opioid) pain medications: oxycodone and fentanyl. In the case of oxycodone, we are interested in whether SJW treatment promotes the metabolism of oxycodone, such that it lowers the effectiveness of standard doses of oxycodone in treating pain problems. For the fentanyl study, we will investigate whether SJW treatment will interfere with the delivery of fentanyl to the brain and diminish it's effectiveness to relieve pain. There is evidence to suggest that SJW treatment may increase the activity of a transporter protein, named P-glycoprotein (Pgp), in the blood-brain barrier (BBB) that protects the brain from exposure to drugs and other dietary and environmental toxins.
NCT00092313	A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-182)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2002-06-01	The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following dental surgery.

Clinical Trial Conditions for Oxycodone Hydrochloride

Condition Name

Condition Name for Oxycodone Hydrochloride
Intervention	Trials
Pain	81
Pain, Postoperative	36
Postoperative Pain	31
Healthy	29

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Oxycodone Hydrochloride
Intervention	Trials
Pain, Postoperative	95
Back Pain	29
Osteoarthritis	27
Low Back Pain	26

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Oxycodone Hydrochloride

Trials by Country

Trials by Country for Oxycodone Hydrochloride
Location	Trials
United States	897
China	30
Canada	25
Finland	20
Italy	17

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Oxycodone Hydrochloride
Location	Trials
New York	60
California	52
Texas	49
Pennsylvania	47
Florida	36

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Oxycodone Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Oxycodone Hydrochloride
Clinical Trial Phase	Trials
Phase 4	145
Phase 3	101
Phase 2/Phase 3	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Oxycodone Hydrochloride
Clinical Trial Phase	Trials
Completed	213
Recruiting	82
Not yet recruiting	75

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Oxycodone Hydrochloride

Sponsor Name

Sponsor Name for Oxycodone Hydrochloride
Sponsor	Trials
Purdue Pharma LP	23
Grünenthal GmbH	19
Pfizer	17

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Oxycodone Hydrochloride
Sponsor	Trials
Other	335
Industry	213
NIH	21

Export unavailable in trial.
Subscribe for complete access.